Raras
Buscar doenças, sintomas, genes...
Albinismo oculo-cutâneo tipo 5
ORPHA:370091CID-10 · E70.3CID-11 · EC23.20OMIM 615312DOENÇA RARA

O albinismo oculocutâneo tipo 5 (OCA5) é uma forma de albinismo que afeta a pele e os olhos, encontrada até hoje em apenas uma família paquistanesa. Caracteriza-se por pele branca, cabelos dourados, sensibilidade à luz (fotofobia), movimentos involuntários dos olhos (nistagmo), desenvolvimento incompleto da fóvea (uma parte do olho importante para a visão nítida) e visão reduzida. Afeta igualmente homens e mulheres, e sua localização genética foi identificada em uma região do cromossomo 4q24, mas o gene exato responsável ainda não foi descoberto.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

O albinismo oculocutâneo tipo 5 (OCA5) é uma forma de albinismo que afeta a pele e os olhos, encontrada até hoje em apenas uma família paquistanesa. Caracteriza-se por pele branca, cabelos dourados, sensibilidade à luz (fotofobia), movimentos involuntários dos olhos (nistagmo), desenvolvimento incompleto da fóvea (uma parte do olho importante para a visão nítida) e visão reduzida. Afeta igualmente homens e mulheres, e sua localização genética foi identificada em uma região do cromossomo 4q24, mas o gene exato responsável ainda não foi descoberto.

Publicações científicas
1.765 artigos
Último publicado: 2026 Apr 2

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
1
pacientes catalogados
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: E70.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (6)
0202010279
Dosagem de aminoácidos (erros inatos)metabolic_test
0202010295
Dosagem de ácidos orgânicos na urinagenetic_test
0202010490
Teste de triagem para erros inatos do metabolismonewborn_screening
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202080013
Teste do pezinho (triagem neonatal)
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
3 sintomas
😀
Face
1 sintomas

+ 5 sintomas em outras categorias

Características mais comuns

100%prev.
Palato ogival
100%prev.
Nistagmo
100%prev.
Morfologia anormal do fundo de olho
100%prev.
Albinismo ocular
100%prev.
Acuidade visual reduzida
100%prev.
Fotofobia
9sintomas
Muito frequente (7)
Sem dados (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 9 características clínicas mais associadas, ordenadas por frequência.

Palato ogivalHigh palate
Muito frequente100%
NistagmoNystagmus
Muito frequente100%
Morfologia anormal do fundo de olhoAbnormal fundus morphology
Muito frequente100%
Albinismo ocularOcular albinism
Muito frequente100%
Acuidade visual reduzidaReduced visual acuity
Muito frequente100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.765PubMed
Últimos 10 anos78publicações
Pico202311 papers
Linha do tempo
2026Hoje · 2026🧪 2018Primeiro ensaio clínico📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Albinismo oculo-cutâneo tipo 5

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
599 papers (10 anos)

Mostrando amostra de 78 publicações de um total de 599

#1

First Report of Oculocutaneous Albinism Type I Among Baka Pygmies From Cameroon.

Pigment cell &amp; melanoma research2026 Jan

Oculocutaneous albinism type 1 (OCA1) caused by pathogenic variants of the TYR gene is an autosomal recessive disorder of pigmentation characterized by reduced biosynthesis of melanin pigment in skin, hair, and eyes. We had the opportunity to examine five East Cameroon Baka rainforest hunter-gatherers (historically called "Pygmies") with albinism and belonging to three different families. Screening of known albinism genes revealed a homozygous missense variant in the TYR gene, NM_000372.5: c.1109T>C; p.Met370Thr. In addition, one patient was also hemizygous for a variant in GPR143, the gene involved in ocular albinism (OA1). Another patient was also heterozygous for the common African and Afro-American 2.7-kb deletion in the OCA2 gene indicating admixture of one parent with neighboring Nzimé Bantu-speaking farmers. This is the first report of the occurrence of OCA1 in African rainforest hunter-gatherers.

#2

Choline and CCL22 Are Prognostic Blood Biomarkers for Hermansky-Pudlak Syndrome Pulmonary Fibrosis.

American journal of respiratory cell and molecular biology2026 Jan 01

Identifying molecular biomarkers of pulmonary fibrosis (PF) would improve monitoring the disease progression and response to treatment. Hermansky-Pudlak syndrome (HPS)PF is an inherited type of progressive PF with accelerated onset of PF in patients with HPS type 1 (HPS-1). HPSPF could serve as a model to study biomarkers of progressive PF, given that all individuals with HPS-1 eventually develop HPSPF. We used a multiomics strategy to discover progressive blood biomarkers that can recognize factors contributing to the fibrotic cascade in the lungs of individuals with HPS. Metabolomic and cytokine/chemokine profiling were performed on serum samples from patients with HPS-1, HPS-1 with PF (HPSPF), HPS-3, HPS-5, or idiopathic PF and healthy volunteers. Metabolomics, cytokine/chemokine, pulmonary function, and age data from subjects with HPS-1 and HPSPF were integrated into a multiomics network. The analysis highlighted alterations in the transsulfuration pathway, arginine metabolism, and redox balance with the progression of PF in HPS-1. Among those, CCL22 and choline were significantly elevated in HPSPF compared with HPS-1 in two independent cohorts together with age and were associated with decline of pulmonary function. In receiver operating characteristic curve analysis, both CCL22 and choline demonstrated high accuracy in predicting PF in subjects with HPS-1 and therefore could serve as prognostic blood biomarkers of HPSPF. We noted similarity in molecular signatures of CCL22 in progressive idiopathic PF and HPSPF. We found that inducible nitric oxide synthase is an upstream regulator of releasing profibrotic mediators (CCL22, CCL24, IL-18, IL-1α, IL-1β), suggesting the therapeutic potential of inducible nitric oxide synthase inhibition in progressive HPSPF.

#3

Platelet secretion defects and increased CD63 expression in Hermansky-Pudlak syndrome: a case report.

Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis2025 Jul 01

Hermansky-Pudlak syndrome (HPS) is an autosomal recessive disorder characterized by clinical features including oculocutaneous albinism (OCA) and bleeding diathesis due to platelet storage pool deficiency. In this article, we report a 12-year-old boy with recurrent epistaxis who was referred to the Iranian Blood Transfusion Organization (IBTO) reference coagulation laboratory for platelet function analysis. Based on the laboratory diagnostic tests in this study and the patient's clinical presentation, the probability of HPS type 2 is more likely.

#4

A novel HPS3 pathogenic nonsense variant associated with Hermansky-Pudlak syndrome type 3 and a platelet dysfunction.

Molecular biology reports2025 Nov 06

Hermansky-Pudlak Syndrome (HPS) is a rare autosomal recessive syndromic type of albinism. It is characterized by oculocutaneous hypopigmentation, platelet dysfunction, and variable systemic involvement depending on the specific subtype. To date, eleven distinct HPS types have been identified, with HPS3 being among the milder forms. Clinical and ophthalmic examinations, followed by whole exome sequencing (WES), Sanger sequencing, and segregation analysis, were performed. Here, we report a case of a 26-year-old Lebanese male patient born to consanguineous parents who presented with oculocutaneous albinism without a history of bleeding or other systemic involvement. WES identified a novel homozygous nonsense variant in the HPS3 gene (NM_032383.5): c.998T > A; p.(Leu333Ter) that co-segregated with the phenotype. The platelet function analysis (PFA-100) revealed a prolonged collagen/epinephrine closure time, accompanied by a normal collagen/ADP response. We report one of the very few HPS3 cases in the Middle East and North Africa region (MENA) and the Arab regions, caused by a novel homozygous nonsense variant associated with platelet dysfunction. In contrast to the founder mutations described in Puerto Rican and Ashkenazi Jewish populations, HPS3 cases in this region appear to result from distinct mutational events, indicating the absence of a common ancestral origin.

#5

A recessive coat color dilution in Dexter cattle attributed to a missense mutation in SLC45A2.

Animal genetics2025 Oct

Three colors of Dexter cattle are currently recognized: black, red, and dun. In Dexters, dun is determined by a recessive genotype of TYRP1 (b/b) that dilutes an otherwise black animal (MC1R genotype ED/-); this variant does not impact red cattle. A subset of Dexters with dilute coat colors described as dark dun/chocolate (CD) or light dun/cream (CL) were identified. Although phenotypically similar to dun, they did not have the expected TYRP1 b/b genotype. Given relationships among the reported individuals, we hypothesized that a novel recessive genotype is causative of CD on a black background and CL on a red background. Whole-genome sequence was generated from four dilute Dexters (three CD and one CL), and one black calf of a CD dam. None of the cattle sequenced had the TYRP1 b/b genotype. The comparison of variants in the five Dexter cattle to those from 226 non-Dexter control cattle resulted in the identification of a missense variant in SLC45A2 (NC_037347.1: g.39790189A>C; XM_002696386.6: c.398A>C) that fit the proposed hypothesis. Sanger sequencing of additional Dexter cattle (n = 227) demonstrated complete segregation of the recessive genotype with the CD and CL phenotypes. The mutation, predicted to result in a substitution of glutamine with proline (XP_002696432.2: p.Gln133Pro) in a transmembrane helix was classified as deleterious by SIFT. Further supporting its implication, SLC45A2 is responsible for coat color dilutions and oculocutaneous albinism type IV in multiple species. Testing for the SLC45A2 variant can be a valuable resource for Dexter breeders interested in coat color.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC618 artigos no totalmostrando 78

2026

First Report of Oculocutaneous Albinism Type I Among Baka Pygmies From Cameroon.

Pigment cell &amp; melanoma research
2025

A novel HPS3 pathogenic nonsense variant associated with Hermansky-Pudlak syndrome type 3 and a platelet dysfunction.

Molecular biology reports
2025

A recessive coat color dilution in Dexter cattle attributed to a missense mutation in SLC45A2.

Animal genetics
2025

Genetic Diagnosis of Oculocutaneous Albinism Type 1A: A Novel TYR Variant.

Clinical case reports
2026

Choline and CCL22 Are Prognostic Blood Biomarkers for Hermansky-Pudlak Syndrome Pulmonary Fibrosis.

American journal of respiratory cell and molecular biology
2025

Platelet secretion defects and increased CD63 expression in Hermansky-Pudlak syndrome: a case report.

Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis
2025

Multiplexed Assays of Variant Effect and Reclassification of TYR Variants in Chinese Patients with Oculocutaneous Albinism.

The Journal of investigative dermatology
2025

Case report: Inflammatory bowel disease in Hermansky-Pudlak syndrome type 3 due to novel variant in HPS3.

Frontiers in genetics
2025

Screening of Clinical Data of Patients with Abnormal Head Posture and Investigation of Abnormal Head Posture Change After Treatment.

Turkish journal of ophthalmology
2024

Efficient genome editing in medaka (Oryzias latipes) using a codon-optimized SaCas9 system.

Journal of Zhejiang University. Science. B
2025

A 65 kilobase deletion of the upstream TYR gene region in a family with oculocutaneous albinism type 1.

Gene
2024

Early diagnosis of immunodeficient patients with partial albinism: The role of hair study and peripheral blood smear.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2025

Impairment of Renal Function in Hermansky-Pudlak Syndrome.

American journal of nephrology
2024

Albinism and Blood Cell Profile: The Peculiar Case of Asinara Donkeys.

Animals : an open access journal from MDPI
2024

[Correlation between refraction and axial length in Albinos].

Journal francais d'ophtalmologie
2024

Comparative transcriptome analysis reveals growth and molecular pathway of body color regulation in turbot (Scophthalmus maximus) exposed to different light spectrum.

Comparative biochemistry and physiology. Part D, Genomics &amp; proteomics
2023

Hermansky-Pudlak Syndrome Type 6 and Renal Failure: A Rare Genetic Disease.

Cureus
2023

[Diagnosis of a case with Hermansky-Pudlak syndrome type 5 through high-throughput sequencing and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism.

Pigment cell &amp; melanoma research
2023

Mutational Analysis of TYR, OCA2, SLC45A2, and TYRP1 Genes Identifies Novel and Reported Mutations in Chinese Families with Oculocutaneous Albinism.

Alternative therapies in health and medicine
2023

Identification and characterization of the compound heterozygous variants of TYR gene in a northern Chinese family with Oculocutaneous albinism type 1.

Pigment cell &amp; melanoma research
2023

A review of treatment of port-wine stains with pulsed dye laser in fitzpatrick skin type IV-VI.

Archives of dermatological research
2023

Low-vision intervention for oculocutaneous albinism in a Tertiary Eye Care Hospital in India.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
2023

[Clinical and molecular genetic analysis of Angelman syndrome with oculocutaneous albinism type 2: A case report and literature review].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
2023

In vitro characterization of the intramelanosomal domain of human recombinant TYRP1 and its oculocutaneous albinism type 3-related mutant variants.

Protein science : a publication of the Protein Society
2023

Hermansky-Pudlak syndrome presenting with paranoid delusion.

CNS spectrums
2023

Ocular findings and a comparative study of hair, skin and iris color in Chinese patients with albinism.

Ophthalmic genetics
2022

Molecular genetic characterization of Congolese patients with oculocutaneous albinism.

European journal of medical genetics
2022

Dermatologic manifestations in patients with the Hermansky-Pudlak syndrome types 1 and 3.

Orphanet journal of rare diseases
2022

AP-3 complex subunit delta gene, ap3d1, regulates melanogenesis and melanophore survival via autophagy in zebrafish (Danio rerio).

Pigment cell &amp; melanoma research
2022

Axial Length Distributions in Patients With Genetically Confirmed Inherited Retinal Diseases.

Investigative ophthalmology &amp; visual science
2022

Identification and characterization of two novel noncoding tyrosinase (TYR) gene variants leading to oculocutaneous albinism type 1.

The Journal of biological chemistry
2022

Lung Transplantation for Pulmonary Fibrosis Associated With Hermansky-Pudlak Syndrome. A Single-center Experience.

Transplantation direct
2022

Protein Biochemistry and Molecular Modeling of the Intra-Melanosomal Domain of Human Recombinant Tyrp2 Protein and OCA8-Related Mutant Variants.

International journal of molecular sciences
2021

Hermansky-Pudlak Syndrome: Identification of Novel Variants in the Genes HPS3, HPS5, and DTNBP1 (HPS-7).

Frontiers in pharmacology
2022

Long-term vision outcomes for patients with albinism and diabetic retinopathy.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2022

The Phenotypic and Mutational Spectrum of the FHONDA Syndrome and Oculocutaneous Albinism: Similarities and Differences.

Investigative ophthalmology &amp; visual science
2021

Genetic Variability in Slovenian Cohort of Patients with Oculocutaneous Albinism.

Acta chimica Slovenica
2022

Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 6.

Pigment cell &amp; melanoma research
2021

Tyrp1 Mutant Variants Associated with OCA3: Computational Characterization of Protein Stability and Ligand Binding.

International journal of molecular sciences
2021

Whole-Exome Sequencing Identified a Novel Homozygous Frameshift Mutation of HPS3 in a Consanguineous Family with Hermansky-Pudlak Syndrome.

BioMed research international
2021

[Study on TYR gene variant from a pedigree with oculocutaneous albinism].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

INADVERTENT GLOBE PENETRATION AND SUBRETINAL INJECTION OF BOTULINUM TOXIN IN A PATIENT WITH OCULOCUTANEOUS ALBINISM.

Retinal cases &amp; brief reports
2021

Genotype-phenotype associations in Danish patients with ocular and oculocutaneous albinism.

Ophthalmic genetics
2021

The first Hermansky-Pudlak syndrome type 9 patient with two novel variants in Chinese population.

The Journal of dermatology
2021

Interstitial Pneumonia Secondary to Hermansky-Pudlak Syndrome Type 4 Treated with Different Antifibrotic Agents.

Internal medicine (Tokyo, Japan)
2020

Identification of two novel mutations in a Japanese patient with Hermansky-Pudlak syndrome type 5.

The Journal of dermatology
2020

Amelanotic melanoma in a patient with oculocutaneous albinism.

Dermatology online journal
2020

A genome-wide scan study identifies a single nucleotide substitution in the tyrosinase gene associated with white coat colour in a red deer (Cervus elaphus) population.

BMC genetics
2019

[Analysis of P gene variations among fourteen patients with oculocutaneous albinism type II].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2019

A novel porcine model reproduces human oculocutaneous albinism type II.

Cell discovery
2019

[Upper crossed syndrome of muscle imbalance in adolescents with tension-type headache].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2019

Genome of the Malawi golden cichlid fish (Melanochromis auratus) reveals exon loss of oca2 in an amelanistic morph.

Pigment cell &amp; melanoma research
2019

Modeling human point mutation diseases in Xenopus tropicalis with a modified CRISPR/Cas9 system.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2019

Bleeding assessment in female patients with the Hermansky-Pudlak syndrome-A case series.

European journal of haematology
2019

Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the TYR gene.

The British journal of ophthalmology
2019

The Molecular Basis of Chemical Chaperone Therapy for Oculocutaneous Albinism Type 1A.

The Journal of investigative dermatology
2018

Predictable and precise template-free CRISPR editing of pathogenic variants.

Nature
2019

In silico screening of deleterious single nucleotide polymorphisms (SNPs) and molecular dynamics simulation of disease associated mutations in gene responsible for oculocutaneous albinism type 6 (OCA 6) disorder.

Journal of biomolecular structure &amp; dynamics
2018

Widespread dynamic and pleiotropic expression of the melanocortin-1-receptor (MC1R) system is conserved across chick, mouse and human embryonic development.

Birth defects research
2018

Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes.

American journal of respiratory cell and molecular biology
2017

[Clinical manifestation and gene analyses of 15 patients with intellectual disability or developmental delay complicated with congenital nystagmus].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2017

OCA2 splice site variant in German Spitz dogs with oculocutaneous albinism.

PloS one
2017

A single base deletion in the SLC45A2 gene in a Bullmastiff with oculocutaneous albinism.

Animal genetics
2017

Two Variants in SLC24A5 Are Associated with "Tiger-Eye" Iris Pigmentation in Puerto Rican Paso Fino Horses.

G3 (Bethesda, Md.)
2017

Clinico-molecular analysis of eleven patients with Hermansky-Pudlak type 5 syndrome, a mild form of HPS.

Pigment cell &amp; melanoma research
2017

Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5.

PloS one
2017

A Japanese Family With Autosomal Dominant Oculocutaneous Albinism Type 4.

Investigative ophthalmology &amp; visual science
2017

A new type of syndromic albinism associated with mutations in AP3D1.

Pigment cell &amp; melanoma research
2016

A cross-sectional examination of visual acuity by specific type of albinism.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2016

Large-Scale Recombinant Expression and Purification of Human Tyrosinase Suitable for Structural Studies.

PloS one
2017

Phacoemulsification and intraocular lens implantation in patients with oculocutaneous albinism.

Ophthalmic genetics
2015

Posterior staphyloma in oculocutaneous albinism: another possible cause of reduced visual acuity.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2015

Cytoplasmic Control of Sense-Antisense mRNA Pairs.

Cell reports
2015

Prenatal genotyping of four common oculocutaneous albinism genes in 51 Chinese families.

Journal of genetics and genomics = Yi chuan xue bao
2015

Two novel splicing mutations in the SLC45A2 gene cause Oculocutaneous Albinism Type IV by unmasking cryptic splice sites.

Journal of human genetics
2015

Refractive errors, visual impairment, and the use of low-vision devices in albinism in Malawi.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2015

Defective PDI release from platelets and endothelial cells impairs thrombus formation in Hermansky-Pudlak syndrome.

Blood
Ver todos os 618 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Albinismo oculo-cutâneo tipo 5.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Albinismo oculo-cutâneo tipo 5

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. First Report of Oculocutaneous Albinism Type I Among Baka Pygmies From Cameroon.
    Pigment cell &amp; melanoma research· 2026· PMID 41521385mais citado
  2. Choline and CCL22 Are Prognostic Blood Biomarkers for Hermansky-Pudlak Syndrome Pulmonary Fibrosis.
    American journal of respiratory cell and molecular biology· 2026· PMID 40720784mais citado
  3. Platelet secretion defects and increased CD63 expression in Hermansky-Pudlak syndrome: a case report.
    Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis· 2025· PMID 40333031mais citado
  4. A novel HPS3 pathogenic nonsense variant associated with Hermansky-Pudlak syndrome type 3 and a platelet dysfunction.
    Molecular biology reports· 2025· PMID 41196426mais citado
  5. A recessive coat color dilution in Dexter cattle attributed to a missense mutation in SLC45A2.
    Animal genetics· 2025· PMID 41101985mais citado
  6. Multiple metastatic eccrine porocarcinoma with squamous differentiation in oculo-cutaneous albinism.
    Indian J Dermatol Venereol Leprol· 2026· PMID 41949185recente
  7. Hermansky-Pudlak Syndrome Type 3 Complicated by Schizophrenia and Crohn's-Like Colitis.
    J Dermatol· 2026· PMID 41906413recente
  8. Haplotype-Based Analysis of OCA2 Variants in Oculocutaneous Albinism.
    Pigment Cell Melanoma Res· 2026· PMID 41905947recente
  9. Quantifying functional vision in a mouse model of oculocutaneous albinism type 1.
    Sci Rep· 2026· PMID 41872298recente
  10. The impact of stigma on people with albinism in Africa: a narrative review.
    J Community Genet· 2026· PMID 41863705recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:370091(Orphanet)
  2. OMIM OMIM:615312(OMIM)
  3. MONDO:0014127(MONDO)
  4. GARD:17598(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Albinismo oculo-cutâneo tipo 5
Compêndio · Raras BR

Albinismo oculo-cutâneo tipo 5

ORPHA:370091 · MONDO:0014127
Prevalência
<1 / 1 000 000
Casos
1 casos conhecidos
Herança
Autosomal recessive
CID-10
E70.3 · Albinismo
CID-11
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C3888401
EuropePMC
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades